$Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study$

Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Blood cancer journal (New York) 2020-05, Vol.10 (5), p.58-58, Article 58
Hauptverfasser:	Mina, Roberto, Belotti, Angelo, Petrucci, Maria Teresa, Zambello, Renato, Capra, Andrea, Di Lullo, Giacomo, Ronconi, Sonia, Pescosta, Norbert, Grasso, Mariella, Monaco, Federico, Cellini, Claudia, Gobbi, Marco, Ballanti, Stelvio, de Fabritiis, Paolo, Mosca-Siez, Maria Letizia, Marchetti, Monia, Liberati, Anna Marina, Offidani, Massimo, Giuliani, Nicola, Ria, Roberto, Musto, Pellegrino, Romano, Alessandra, Sonneveld, Pieter, Boccadoro, Mario, Larocca, Alessandra
Format:	Artikel
Sprache:	eng
Schlagworte:	692/308/2779/109/1941 692/699/67/1990/804 Aged Antineoplastic Agents - therapeutic use Biomedical and Life Sciences Biomedicine Bortezomib - therapeutic use Cancer Research Correspondence Dexamethasone - therapeutic use Female Hematology Humans Male Multiple Myeloma - drug therapy Neoplasm Recurrence, Local - drug therapy Oncology Survival Analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:
ISSN:	2044-5385 2044-5385
DOI:	10.1038/s41408-020-0326-1